Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 8
1975 36
1976 29
1977 71
1978 84
1979 138
1980 237
1981 263
1982 332
1983 437
1984 501
1985 530
1986 559
1987 607
1988 576
1989 597
1990 568
1991 603
1992 536
1993 504
1994 434
1995 449
1996 421
1997 389
1998 362
1999 334
2000 336
2001 276
2002 281
2003 281
2004 282
2005 252
2006 289
2007 267
2008 232
2009 232
2010 212
2011 226
2012 204
2013 210
2014 203
2015 177
2016 179
2017 146
2018 142
2019 133
2020 147
2021 100
Text availability
Article attribute
Article type
Publication date

Search Results

13,901 results
Results by year
Filters applied: . Clear all
Page 1
Prazosin in the treatment of PTSD.
Green B. Green B. J Psychiatr Pract. 2014 Jul;20(4):253-9. doi: 10.1097/01.pra.0000452561.98286.1e. J Psychiatr Pract. 2014. PMID: 25036580 Review.
A review of this literature was conducted via a search of MEDLINE and SUMMON, using keywords such as PTSD, prazosin, treatment, and resistance. At least 10 clinical studies of prazosin in the treatment of PTSD, including open-label and randomized controlled trials, …
A review of this literature was conducted via a search of MEDLINE and SUMMON, using keywords such as PTSD, prazosin, treatment, and r …
Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.
Simon PY, Rousseau PF. Simon PY, et al. Can J Psychiatry. 2017 Mar;62(3):186-198. doi: 10.1177/0706743716659275. Epub 2016 Jul 19. Can J Psychiatry. 2017. PMID: 27432823 Free PMC article. Review.
OBJECTIVE: The present review aims to assess the clinical efficacy and safety of the alpha-1-adrenergic antagonist prazosin as primary pharmacologic treatment for post-traumatic stress disorder (PTSD). ...The evaluation concerned 276 patients exposed to civilian trauma (19 …
OBJECTIVE: The present review aims to assess the clinical efficacy and safety of the alpha-1-adrenergic antagonist prazosin as primar …
[Prazosin].
[No authors listed] [No authors listed] G Ital Cardiol. 1979;9(6):640-6. G Ital Cardiol. 1979. PMID: 385411 Review. Italian. No abstract available.
[Terazosin].
Schäfers RF, Michel MC. Schäfers RF, et al. Dtsch Med Wochenschr. 1998 Apr 9;123(15):459-60. doi: 10.1055/s-0029-1233226. Dtsch Med Wochenschr. 1998. PMID: 9581161 Review. German. No abstract available.
Clinical pharmacokinetics of prazosin.
Jaillon P. Jaillon P. Clin Pharmacokinet. 1980 Jul-Aug;5(4):365-76. doi: 10.2165/00003088-198005040-00004. Clin Pharmacokinet. 1980. PMID: 6994981 Review.
Preliminary studies in humans indicate that pathways for biotransformation of prazosin are similar to those observed in the rat and dog. Only 6% of prazosin is excreted unchanged, mainly in the urine. ...In both cases, the plasma free fraction of prazosin is …
Preliminary studies in humans indicate that pathways for biotransformation of prazosin are similar to those observed in the rat and d …
Drug therapy. Prazosin.
Koch-Weser J, Graham RM, Pettinger WA. Koch-Weser J, et al. N Engl J Med. 1979 Feb 1;300(5):232-6. doi: 10.1056/NEJM197902013000505. N Engl J Med. 1979. PMID: 366403 Review. No abstract available.
Comparative efficacy of imagery rehearsal therapy and prazosin in the treatment of trauma-related nightmares in adults: A meta-analysis of randomized controlled trials.
Yücel DE, van Emmerik AAP, Souama C, Lancee J. Yücel DE, et al. Sleep Med Rev. 2020 Apr;50:101248. doi: 10.1016/j.smrv.2019.101248. Epub 2019 Nov 28. Sleep Med Rev. 2020. PMID: 31855732 Review.
The American Academy of Sleep Medicine task force recently listed IRT as the recommended treatment for trauma-related nightmares and changed the recommendation of prazosin to 'may be used'. This new recommendation was based on a single prazosin trial and not on a me …
The American Academy of Sleep Medicine task force recently listed IRT as the recommended treatment for trauma-related nightmares and changed …
The mechanism of the action of Minipress. Examinations in hypertension.
Török E, Bíró V, Podmaniczky M. Török E, et al. Ther Hung. 1989;37(2):90-8. Ther Hung. 1989. PMID: 2573964 Review.
The specific competitive alpha 1-postsynaptic blocking action and haemodynamic effects of prazosin (Minipress) have been summarized. Prazosin causes dilatation of arterioles and veins, reduces total peripheral resistance as well as preload and afterload. ...Earlier …
The specific competitive alpha 1-postsynaptic blocking action and haemodynamic effects of prazosin (Minipress) have been summarized. …
Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
Colucci WS. Colucci WS. Ann Intern Med. 1982 Jul;97(1):67-77. doi: 10.7326/0003-4819-97-1-67. Ann Intern Med. 1982. PMID: 6124197 Review.
In contrast to non-subtype-selective alpha-adrenergic antagonists and direct-acting vasodilators, prazosin's hypotensive action is accompanied by little or no increase in heart, rate, plasma renin, or plasma norepinephrine. ...Attenuation of some or all of prazos
In contrast to non-subtype-selective alpha-adrenergic antagonists and direct-acting vasodilators, prazosin's hypotensive actio …
Clinical Use of Prazosin in a Patient With Acute Stress Disorder: A Case Report.
Srivastava AA, Opler DJ. Srivastava AA, et al. J Psychiatr Pract. 2020 May;26(3):246-248. doi: 10.1097/PRA.0000000000000468. J Psychiatr Pract. 2020. PMID: 32421296
Prazosin is an alpha-1 blocker that is commonly given to patients with posttraumatic stress disorder (PTSD) to reduce nightmares and flashbacks. ...He was reporting flashbacks and nightmares of the accident, but after being treated with prazosin, his symptoms comple
Prazosin is an alpha-1 blocker that is commonly given to patients with posttraumatic stress disorder (PTSD) to reduce nightmares and
13,901 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page